News & Updates
Filter by Specialty:
Esketamine outperforms quetiapine in head-to-head depression trial
30 Oct 2023
byJairia Dela Cruz
In patients with treatment-resistant depression, esketamine nasal spray appears to have superior efficacy compared with extended-release quetiapine when used in combination with conventional antidepressants.
Esketamine outperforms quetiapine in head-to-head depression trial
30 Oct 2023Remnant cholesterol ups GDM risk in pregnant women
29 Oct 2023
Increased levels of remnant cholesterol (RC) appear to elevate the risk of gestational diabetes mellitus (GDM), independent of traditional risk factors, suggests a study. Moreover, pregnant women with high prepregnancy body mass index (BMI), high triglyceride (TG), and high RC levels are at greater GDM risk.
Remnant cholesterol ups GDM risk in pregnant women
29 Oct 2023Antiviral therapy safe, effective in children with immune-tolerant HBV infection
28 Oct 2023
Treatment with antiviral therapy is beneficial and generally tolerated in children with chronic hepatitis B virus (HBV) infection in the immune-tolerant stage, according to the results of a systematic review and meta-analysis.